Literature DB >> 15780201

Predictive model of blood-brain barrier penetration of organic compounds.

Xiao-lei Ma1, Cheng Chen, Jie Yang.   

Abstract

AIM: To build up a theoretical model of organic compounds for the prediction of the activity of small molecules through the blood-brain barrier (BBB) in drug design.
METHODS: A training set of 37 structurally diverse compounds was used to construct quantitative structure-activity relationship (QSAR) models. Intermolecular and intramolecular solute descriptors were calculated using molecular mechanics, molecular dynamics simulations, quantum chemistry and so on. The QSAR models were optimized using multidimensional linear regression fitting and stepwise method. A test set of 8 compounds was evaluated using the models as part of a validation process.
RESULTS: Significant QSAR models (R=0.955, s=0.232) of the BBB penetration of organic compounds were constructed. BBB penetration was found to depend upon the polar surface area, the octanol/water partition coefficient, Balaban Index, the strength of a small molecule to combine with the membrane-water complex, and the changeability of the structure of a solute-membrane-water complex.
CONCLUSION: The QSAR models indicate that the distribution of organic molecules through BBB is not only influenced by organic solutes themselves, but also relates to the properties of the solute-membrane-water complex, that is, interactions of the molecule with the phospholipid-rich regions of cellular membranes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780201     DOI: 10.1111/j.1745-7254.2005.00068.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  23 in total

1.  Exploration of 3,6-dihydroimidazo(4,5-d)pyrrolo(2,3-b)pyridin-2(1H)-one derivatives as JAK inhibitors using various in silico techniques.

Authors:  Radhakrishnan S Jisha; Lilly Aswathy; Vijay H Masand; Jayant M Gajbhiye; Indira G Shibi
Journal:  In Silico Pharmacol       Date:  2017-10-12

2.  QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.

Authors:  Liying Zhang; Hao Zhu; Tudor I Oprea; Alexander Golbraikh; Alexander Tropsha
Journal:  Pharm Res       Date:  2008-06-14       Impact factor: 4.200

Review 3.  Molecular determinants of blood-brain barrier permeation.

Authors:  Werner J Geldenhuys; Afroz S Mohammad; Chris E Adkins; Paul R Lockman
Journal:  Ther Deliv       Date:  2015-08-25

4.  Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents.

Authors:  Joanna Matysiak; Małgorzata Juszczak; Monika M Karpińska; Ewa Langner; Katarzyna Walczak; Marta Lemieszek; Alicja Skrzypek; Wojciech Rzeski; Andrzej Niewiadomy
Journal:  Monatsh Chem       Date:  2015-04-02       Impact factor: 1.451

5.  Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.

Authors:  Oscar M Bautista-Aguilera; Gerard Esteban; Mourad Chioua; Katarina Nikolic; Danica Agbaba; Ignacio Moraleda; Isabel Iriepa; Elena Soriano; Abdelouahid Samadi; Mercedes Unzeta; José Marco-Contelles
Journal:  Drug Des Devel Ther       Date:  2014-10-13       Impact factor: 4.162

6.  Computational Analysis of Gynura bicolor Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor.

Authors:  Lina Rozano; Muhammad Redha Abdullah Zawawi; Muhamad Aizuddin Ahmad; Indu Bala Jaganath
Journal:  Adv Bioinformatics       Date:  2017-08-08

7.  Virtual Screening and Statistical Analysis in the Design of New Caffeine Analogues Molecules with Potential Epithelial Anticancer Activity.

Authors:  Josivan da Silva Costa; Karina da Silva Lopes Costa; Josiane Viana Cruz; Ryan da Silva Ramos; Luciane Barros Silva; Davi Do Socorro Barros Brasil; Carlos Henrique Tomich de Paula da Silva; Cleydson Breno Rodrigues Dos Santos; Williams Jorge da Cruz Macedo
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

8.  New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.

Authors:  Kamila Czarnecka; Małgorzata Girek; Karolina Maciejewska; Robert Skibiński; Jakub Jończyk; Marek Bajda; Jacek Kabziński; Przemysław Sołowiej; Ireneusz Majsterek; Paweł Szymański
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

9.  Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2).

Authors:  Mohammad Firoz Khan; Nusrat Nahar; Ridwan Bin Rashid; Akhtaruzzaman Chowdhury; Mohammad A Rashid
Journal:  BMC Complement Altern Med       Date:  2018-02-02       Impact factor: 3.659

10.  Anti-Inflammatory and Antioxidant Activities of Terpene- and Polyphenol-Rich Premna odorata Leaves on Alcohol-Inflamed Female Wistar Albino Rat Liver.

Authors:  Abeer H Elmaidomy; Hani A Alhadrami; Elham Amin; Hanan F Aly; Asmaa M Othman; Mostafa E Rateb; Mona H Hetta; Usama Ramadan Abdelmohsen; Hossam M Hassan
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.